Stefan Habringer

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Acute Lymphoblastic Leukemia

Oxide Nanoparticles

Top Venues

Annals of hematology

Nature communications

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Markus Tölle, Nicola Gökbuget, Stefan Habringer, Ulrich Bernd Keller, Stefan Schwartz
Plasmapheresis effectively abrogates severe liver toxicity of pegaspargase in a patient with acute lymphoblastic leukemia. Annals of hematology 103 (8) (2024)
Stefan Habringer, Jana Ihlow, Karsten Kleo, Anna Klostermann, Max Schmidt, Lidan Chai, Maren Knödler, Serge Leyvraz, Christian Sigler, Bruno Valentin Sinn, Georg Maschmeyer, Yvette Jegodka, Manuela Benary, Claus-Eric Ott, Ingeborg Tinhofer, Reinhold Schäfer, Markus Möbs, Ulrich Bernd Keller, Ulrich Keilholz, Damian T Rieke
A diagnostic challenge of KIT p.V559D and BRAF p.G469A mutations in a paragastric mass. The oncologist (2024)
Markus Tölle, Nicola Gökbuget, Stefan Habringer, Ulrich Bernd Keller, Stefan Schwartz
Plasmapheresis effectively abrogates severe liver toxicity of pegaspargase in a patient with acute lymphoblastic leukemia. Annals of hematology (2024)
Markus Tölle, Nicola Gökbuget, Stefan Habringer, Ulrich Bernd Keller, Stefan Schwartz
Plasmapheresis effectively abrogates severe liver toxicity of pegaspargase in a patient with acute lymphoblastic leukemia. Annals of hematology 103 (8) (2024)
Markus Tölle, Nicola Gökbuget, Stefan Habringer, Ulrich Bernd Keller, Stefan Schwartz
Plasmapheresis effectively abrogates severe liver toxicity of pegaspargase in a patient with acute lymphoblastic leukemia. Annals of hematology 103 (8) (2024)
Markus Tölle, Nicola Gökbuget, Stefan Habringer, Ulrich Bernd Keller, Stefan Schwartz
Plasmapheresis effectively abrogates severe liver toxicity of pegaspargase in a patient with acute lymphoblastic leukemia. Annals of hematology 103 (8) (2024)
Jonas S Heitmann, Claudia Tandler, Maddalena Marconato, Annika Nelde, Timorshah Habibzada, Susanne M Rittig, Christian M Tegeler, Yacine Maringer, Simon U Jaeger, Monika Denk, Marion Richter, Melek T Oezbek, Karl-Heinz Wiesmüller, Jens Bauer, Jonas Rieth, Marcel Wacker, Sarah M Schroeder, Naomi Hoenisch Gravel, Jonas Scheid, Melanie Märklin, Annika Henrich, Boris Klimovich, Kim L Clar, Martina Lutz, Samuel Holzmayer, Sebastian Hörber, Andreas Peter, Christoph Meisner, Imma Fischer, Markus W Löffler, Caroline Anna Peuker, Stefan Habringer, Thorsten O Goetze, Elke Jäger, Hans-Georg Rammensee, Helmut R Salih, Juliane Sarah Walz
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency. Nature communications 14 (1) (2023)
Markus Schick, Le Zhang, Sabine Maurer, Hans Carlo Maurer, Konstandina Isaakaidis, Lara Schneider, Upayan Patra, Kathrin Schunck, Elena Rohleder, Julia Hofstetter, Apoorva Baluapuri, Anna Katharina Scherger, Julia Slotta-Huspenina, Franziska Hettler, Julia Weber, Thomas Engleitner, Roman Maresch, Jolanta Slawska, Richard Ian Lewis, Rouzanna Istvanffy, Stefan Habringer, Katja Steiger, Armin Baiker, Robert A J Oostendorp, Christoph Cornelius Miething, Hans-Peter Lenhof, Florian Bassermann, Bjoern Chapuy, Matthias Wirth, Elmar Wolf, Roland Rad, Stefan Müller, Ulrich Bernd Keller
Genetic alterations of the SUMO isopeptidase SENP6 drive lymphomagenesis and genetic instability in diffuse large B-cell lymphoma. Nature communications 13 (1) (2022)
Josefina Doffo, Stefanos A Bamopoulos, Hazal Köse, Felix Orben, Chuanbing Zang, Miriam Pons, Alexander T den Dekker, Rutger W W Brouwer, Apoorva Baluapuri, Stefan Habringer, Maximillian Reichert, Anuradha Illendula, Oliver H Krämer, Markus Schick, Elmar Wolf, Wilfred F J Van IJcken, Irene Esposito, Ulrich Bernd Keller, Günter Schneider, Matthias Wirth
NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer. Proceedings of the National Academy of Sciences of the United States of America 119 (9) (2022)
Richard Ian Lewis, H Carlo Maurer, Nikita Singh, Irene Gonzalez-Menendez, Matthias Wirth, Markus Schick, Le Zhang, Konstandina Isaakidis, Anna Katharina Scherger, Veronika Schulze, Junyan Lu, Thorsten Zenz, Katja Steiger, Roland Rad, Leticia Quintanilla-Martinez, Marion Espeli, Karl Balabanian, Ulrich Bernd Keller, Stefan Habringer
CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness. Leukemia 35 (10) (2021)